Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
ANNOUNCEMENT
Case Report
Case Series
Clinicodermoscopic Challenge
Clinicopathologic Challenge
Correspondence
Editorial
Faculty’s Forum
Image Correspondence
Innovations and Ideas
Letter to Editor
Original Article
Post Graduate Thesis Section
Quiz
Research Methodology and Publishing
Resident’s Forum
Review Article
Reviewers 2023
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
ANNOUNCEMENT
Case Report
Case Series
Clinicodermoscopic Challenge
Clinicopathologic Challenge
Correspondence
Editorial
Faculty’s Forum
Image Correspondence
Innovations and Ideas
Letter to Editor
Original Article
Post Graduate Thesis Section
Quiz
Research Methodology and Publishing
Resident’s Forum
Review Article
Reviewers 2023
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
ANNOUNCEMENT
Case Report
Case Series
Clinicodermoscopic Challenge
Clinicopathologic Challenge
Correspondence
Editorial
Faculty’s Forum
Image Correspondence
Innovations and Ideas
Letter to Editor
Original Article
Post Graduate Thesis Section
Quiz
Research Methodology and Publishing
Resident’s Forum
Review Article
Reviewers 2023
Short Communication
View/Download PDF

Translate this page into:

Quiz
1 (
1
); 65-66
doi:
10.25259/IJPGD_16_2022

Quiz: Drugs in Dermatology

Consultant Dermatologist, Department of DVL, Amrutha Skin Hospital, Konaseema, Andhra Pradesh, India
Corresponding author: Dr.Satti Surya Amrutha Bindu, Consultant Dermatologist, Department of DVL, Amrutha Skin Hospital, Konaseema, Andhra Pradesh, India. amruthabindu92@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Bindu SS. Quiz: Drugs in Dermatology. Indian J Postgrad Dermatol 2023;1:65-6.

QUESTIONS

  1. Curling factor is the other name for which drug?

  2. Name the topical retinoid with least irritation?

  3. 5 mg of Prednisolone is equivalent to how much strength of triamcinolone acetonide?

  4. What is the chemical name of dapsone?

  5. Name the drug derived from soil bacterium ‘Streptomyces tsukubaensis’?

  6. Bedaquiline is the drug used for which dermatological disease?

  7. Lebrikizumab acts against which cytokine?

  8. PRIDE complex occurs due to which class of drugs?

  9. Acyclovir belongs to which pregnancy category?

  10. Which HLA typing is associated with allopurinol induced SJS/TEN?

  11. Which drug causes lumpy bumpy elastic fibers?

  12. Which is the first FDA approved topical treatment for facial erythema in rosacea?

  13. Prilocaine can be dangerous on systemic absorption as it is converted to ---?

  14. Drug of choice for confluent and reticulated papillomatosis?

  15. Most common drug causing non-pigmented fixed drug eruption?

  16. The maximum recommended rate of usage of calcipotriol ointment per week in Psoriasis?

  17. According to dermatological guidelines, cut off creatinine levels for cyclosporine dose adjustment?

  18. Dose of Azathioprine is adjusted according to which enzyme level?

  19. Life threatening complication of clofazimine?

  20. What is the first topical drug approved for the treatment of acne vulgaris that targets hormonal pathogenesis of acne?

Answers

  1. Griseofulvin

  2. Trifarotene 0.005% cream

  3. 4 mg

  4. 4,4’- Diamino diphenyl sulfone

  5. Tacrolimus

  6. Leprosy

  7. IL-13

  8. EGFR inhibitors

  9. Category B

  10. HLA – B*5801

  11. Penicillamine

  12. Brimonidine

  13. Ortho-toluidine, which can cause methemoglobinemia in predisposed individuals

  14. Minocycline

  15. Pseudoephedrine

  16. 100 g/week

  17. 30% above baseline

  18. Thiopurine methyl transferase

  19. Small bowel enteropathy

  20. 1% Clascoterone cream

Declaration of patient consent

Patient’s consent not required as there are no patients in this study.

Conflicts of interest

There are no conflicts of interest.

Financial support and sponsorship

Nil.


Fulltext Views
547

PDF downloads
391
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections